Related Experiment Videos
Insights
This study identifies a syndrome in children with optic nerve hypoplasia and absent septum pellucidum, often linked to endocrine dysfunction. Early recognition and growth monitoring are crucial for potential treatment with human growth hormone.
Area of Science:
- Pediatric Endocrinology
- Neuro-ophthalmology
- Developmental Biology
Background:
- Optic nerve hypoplasia (ONH) is a congenital condition affecting vision.
- Absent septum pellucidum (ASP) is a brain malformation often associated with endocrine issues.
- Syndromic presentations of ONH and ASP require further characterization.
Purpose of the Study:
- To describe a specific syndrome involving ONH, ASP, and endocrinopathies.
- To emphasize the importance of early diagnosis and monitoring in affected children.
- To highlight potential therapeutic interventions for growth abnormalities.
Main Methods:
- Case series describing four pediatric patients.
- Clinical evaluation including ophthalmological and endocrinological assessments.
- Review of patient growth parameters and response to treatment.
Main Results:
- All four patients presented with optic nerve hypoplasia and absent septum pellucidum.
- Varied endocrinological dysfunctions were observed in the affected children.
- Short stature was a notable feature in some patients.
Conclusions:
- A recognizable syndrome combining ONH, ASP, and endocrine dysfunction exists in children.
- Prompt recognition and longitudinal growth monitoring are essential.
- Availability of human growth hormone offers a potential treatment for short stature in this population.
Abstract:
Four children are described who had hypoplastic optic nerves, absent septa pellucida, and various types of endocrinological dysfunction. The importance is stressed of recognizing this syndrome and of following up the growth of the patient, because now that human growth hormone is available the short stature of some blind children may be susceptible to treatment.